Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections

Molecular Medicine Today

Volumn 5, Issue 12, 1999, Pages 532-537

  Flock, Jan Ingmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BINDING PROTEIN; COLLAGEN; PROTEIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; EXTRACELLULAR MATRIX; IMMUNOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; IMMUNIZATION, PASSIVE; RATS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINATION;

EID: 0032701437     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01597-X     Document Type: Review

References (39)

1. Hiramatsu K. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am. J. Med. 104:1998;7-10.
2. Poole-Warren L.A.et al. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin. Nephrol. 35:1991;198-206.
3. Greenberg D.P., Ward J.I., Bayer A. Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits. Infect. Immun. 55:1987;3030-3034.
4. Watson D.L. Vaccination against experimental staphylococcal mastitis in ewes. Res. Vet. Sci. 45:1988;16-21.
5. Lee J.C.et al. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect. Immun. 65:1997;4146-4151.
6. McKenney D.et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284:1999;1523-1527.
7. Balaban N.et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science. 280:1998;438-440.
8. Foster T.J., Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:1998;484-488.
9. Patti J.M., Allen B.L., McGavin M.J., Hook M. MSCRAMM mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:1994;585-617.
10. Kronvall G., Jönsson K. Receptins: a novel term for an expanding spectrum of natural and engineered microbial proteins with binding properties for mammmalian proteins. J. Mol. Recogn. 12:1999;1-7.
11. Navarre W., Schneewind O. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in Gram-positive bacteria. Mol. Microbiol. 14:1994;115-121.
12. Palma M., Wade D., Flock M., Flock J-I. Multiple binding sites in the interaction between fibrinogen and an extracellular fibrinogen binding protein from Staphylococcus aureus. J. Biol. Chem. 273:1998;13177-13181.
13. Palma M., Haggar A., Flock J-I. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J. Bacteriol. 181:1999;2840-2845.
14. Pei L.et al. Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis. Infect. Immun. 67:1999;4525-4530.
15. Greene C.et al. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin binding proteins and studies on the expression of fnb genes. Mol. Microbiol. 17:1995;1143-1152.
16. McDevitt D., Francois P., Vaudaux P., Foster T.J. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:1994;237-248.
17. Patti J.M.et al. The Staphylococcus aureus collagen adhesion is a virulence determinant in experimental septic arthritis. Infect. Immun. 62:1994;152-161.
18. Hienz S., Schennings T., Heimdahl A., Flock J-I. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J. Infect. Dis. 174:1996;83-88.
19. Moreillon P.et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:1995;4738-4743.
20. Flock J.-I., Hienz S., Schennings T., Heimdahl A. Reconsideration of the role for fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect. Immun. 64:1996;1876-1878.
21. Ryding U.et al. Expression of collagen binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J. Infect. Dis. 176:1997;1096-1099.
22. Brokke P., Dankert J., Carballo J., Feijen J. Adherence of coagulase- negative staphylococci onto polyethylene catheters in vitro and in vivo: a study on the influence of various plasma proteins. J. Biomater. Appl. 5:1991;204-226.
23. Fischer B.et al. Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J. Orthop. Res. 14:1996;914-920.
24. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 237:1987;1588-1595.
25. Casolini F.et al. Antibody response to fibronectin-binding protein A in patients with Staphylococcus aureus infections. Infect. Immun. 66:1998;5433-5442.
26. House-Pompeo K.et al. Conformational change in the fibronectin binding MSCRAMMs are induced by ligand binding. J. Biol. Chem. 271:1996;1379-1384.
27. Penkett C.J.et al. NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding protein. J. Mol. Biol. 274:1997;152-159.
28. Speziale P.et al. A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae. J. Biol. Chem. 271:1996;1371-1378.
29. Luk M-C.J., Flock J-I., Wadström T. Detection in rabbit sera of blocking antibodies against Staphylococcal fibronectin binding protein by enzyme linked immunosorbent assay. FEMS Immunol. Microbiol. 47:1989;505-510.
30. Ciborowski P., Flock J-I., Wadström T. Immunological response to a Staphylococcus aureus fibronectin binding protein. J. Med. Microbiol. 37:1992;376-381.
31. Schennings T., Heimdahl K., Coster K., Flock J-I. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb. Pathog. 15:1993;227-236.
32. Sun Q., Smith G.M., Zahradka C., McGavin M.J. Identification of D-motif epitopes in Staphylococcus aureus fibronecin-binding protein for the production of antibody inhibitors of fibronectin binding. Infect. Immun. 65:1997;537-543.
33. Brennan F.R.et al. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J. Virol. 73:1999;930-938.
34. Brennan F.R.et al. Immunogenicity of peptides derived from a fibronectin binding protein (FnBP) D domain of S. aureus expressed on two different plant viruses. Vaccine. 17:1999;1846-1857.
35. McDevitt D., Francois P., Vaudaux P., Foster T. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol. Microbiol. 16:1995;895-907.
36. Mamo W., Jonsson P., Muller H.P. Opsonization of Staphylococcus aureus with a fibronectin binding protein antiserum induces protection in mice. Microb. Pathog. 19:1995;49-55.
37. Rozalska B., Wadström T. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Scand. J. Immunol. 37:1993;575-580.
38. Nilsson I.M.et al. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus mediated septic death. J. Clin. Invest. 101:1998;2640-2649.
39. Mamo W.et al. Vaccination against Staphylococcus aureus mastitis; Immunological response of mice vaccinated with fibronectin binding proteins (FnBPs) to challenge with S. aureus. Vaccine. 12:1994;988-992.